Send us a text

Dr. Bobby Reddy, MD is the Chief Operating Officer and Co-Founder of Pi Health ( https://www.pihealth.ai/ ), a health technology and clinical research company committed to empowering life sciences companies to develop medicines faster and reach diverse patient populations. Dr. Reddy leads global operations, business development, and commercial activities with the mission of driving equal access to innovative medicines and clinical trials for patients around the world.

Previously, Dr. Reddy served in leadership positions at BeiGene and AstraZeneca.

At BeiGene, Dr. Reddy was Executive Director of Applied Innovation, a technology incubator in the Office of the CEO, which developed novel technologies to improve R&D and commercial capabilities. In this role, Dr. Reddy was the co-inventor of multiple patented technology applications which have successfully undergone enterprise adoption. He also built and managed multidisciplinary, global teams who led strategy, business development, global operations, and legal activities to drive development, implementation and growth of incubated technologies and companies.

At AstraZeneca, Dr. Reddy was Head of Oncology Regulatory Science and Innovation, where he was a member of the global Oncology Regulatory Science and Strategy leadership team.

Previous to Dr. Reddy’s roles in pharma and biotech, Dr. Reddy was faculty of Harvard Medical School and a physician scientist and clinical dermatologist at Massachusetts General Hospital. His research focused on investigating the role of genetic and immunologic factors in melanoma development and progression, along with the development of novel therapeutic strategies.

Dr. Reddy is also an alumnus of the Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program, through which he conducted research at the National Cancer Institute.

Dr. Reddy completed an Internal Medicine internship at Brigham and Women’s Hospital, during which he was given the Dunne Award for Humanism in Medicine by Harvard Medical School. He subsequently completed a Dermatology residency at Columbia University Medical Center, where he served as a Chief Resident during his final year of training. After residency, he completed a Melanoma Fellowship at Massachusetts General Hospital/Harvard Medical School.

Dr. Reddy obtained his M.D. with Alpha Omega Alpha honors from Rutgers–New Jersey Medical School.

Dr. Reddy is a board-certified dermatologist and maintains an active clinical practice caring for patients at Massachusetts General Hospital, where he also teaches and mentors medical students and trainees.

Important Episode Link - Pi Health Cancer Hospital -

https://www.pihealthcancerhospital.com/

#BobbyReddy #PiHealth #Dermatology #Oncology #Melanoma #Cancer #ElectronicHealthRecords #GenerativeAI #CDSCO #ClinicalTrials #India #CentralDrugsStandardControlOrganisation #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #Research

Support the show